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ABSTRACT
This study examined the effect of creatine supplementation on power output during repeated
bouts of high intensity cycling. Using a double blind protocol, 14 hained male cyclists were
randomly divided into placebo (P) and creatine (Cr) groups. They completed five tests on a
mechanically braked cycle ergometer, each separated by at least 48 hours of rest. The tests
included a Wingate anaerobic power test, a maximum oxygen consumption (VOrmax) test, and
three recovery tests. The recovery tests consisted of four,45-second maximal intervals separated
by 45 seconds, 90 seconds, or 135 seconds of active recovery. Creatine subjects ingested 25 gof
creatine per day for 5 days and 5 g per day thereafter until testing was completed; P consumed a
similar quantity of a placebo each day. The following measures were made during the recovery
tests: mean and peak power, HR, VO2, and blood lactate. Additionally, changes in percent
fatigue, lean body mass (LBM), and creatinine excretion were calculated. Data were analyzed
with a three-way repeated measures ANOVA for group X test X bout; a Tukey post-hoc HSD
analysis was used to test for group differences when indicated. There were no significant
differences in LBM, HR, VO2, %o fatigae, and peak and mean power output over time and
between groups and recovery tests. In conclusion, creatine supplementation did not have any
demonstrative effects on four, 45-second supramaximal cycling bouts with active recovery
periods of45 to 135 seconds.
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Chapter 1
INTRODUCTION
Purpose of the Study
All levels of athletes seek the competitive edge. This may account for the
widespread use of illegal drugs in spor! and the high sales figures for many nutritional
supplements with purported ergogencity, such as creatine monohydrate, DFIEd and
androstenedione (Maughaq 1995). Of the aforementioned supplements, creatine has
been the most widely studied by scientists and consumed by athletes (Bosco, Tihanyi,
Pupcspk, Kovacs, Gabossy, Pulvirenti, Tranquilli, Foti, Viru, & Viru, 1997; Brannon,
Adams, Conniff, & Baldwin, 1997;Clark, 1997;Earnest, Almada, & Mitchell,1997;
Harris, Viru, Greenhaff, & Hultman, 1993; Kreider, Ferreira, Wilson, Grindstaff, Plis,
Reinardy, Cantler, & Almada, 1997; Volek, Kraemer, Bush, Boetes,Incledon, Clark, &
Lynch, 1997).
Data from many of the aforementioned studies show that creatine ingestion
improves a person's ability to maintain power output during repeated bouts of high
intensity exercise. This improved performance has been attributed to enhanced ATP
resynthesis during recovery @alsorq Harridge, Soderlund, Sjodin, & Ekblom, 1993,
Balsom, Soderlund, Sjodin & Hultmarq 1995; Earnest et al., 1997;Birch. Noble, &
Greenhaff, 1994; Kreider et al., 1997) Based onthese data, therefore, creatine
supplementation may enhance performance in sports that require frequent bouts of high
intensity exercise, such as road cycling (Maughan, 1995).
The ability of creatine supplementation to enhance cycling performance, for
instance, is shown by studies that report improved power output during short, repeated
bouts of high intensity cycling (Balsom et a1.,1995; Balsom et al., 1993; Birch et al.,
1994;Casey, Constantin-Teodosiu, Howell, Hultmaq & Greenhaft, 1996; Dawson,
Cutler, Moody, Lawrence, Goodman, & Randall, 1995;Earnest et al., 1997; Kreider et
a1.,1997). The extension of these findings to the competitive cycling arena, however, is
timited by several factors. First, none of the subjects in the aforementioned studies were
trained cyclists. Second, passive rather than active recovery was used in these studies;
the opportunity for passive recovery rarely occurs during competitive road cycling.
Another factor that limits the applicability of these studies to the competitive arena is the
short duration of the cycling bouts, which lasted for less than 10 seconds in several
studies (Balsom et a1.,1993; Balsom et al., 1995; Kreider et al., 1997). In road racing,
cyclists often perform several consecutive 30 to 60 second high intensity effiorts such as
during a series of attacks, or for the final sprint set-up. Thus, it remains to be seen if
creatine supplementation benefits a trained cyclist in a more applied setting. The purpose
of this study was to examine the effect of creatine supplementation on power output in
trained cyclists during repeated bouts of relatively prolonged, high-intensity cycling.
Whereas the ability of creatine to increase pou'er output during repeated bouts of
high intensity exercise is well documented, there is little information on the minimum
recovery time needed between work bouts to maintain power output. A work to rest ratio
of l:5 has been used in many studies (Balsom et al., 1993; Balsom et al., 1995; Birch et
3a1.,1994:' Earnest et al., 1997; Kreider et a1., L997). A shorter work to rest ratio of l:2
was used, however, by Greenhaffet al. (1993). They demonstrated that PCr resynthesis
was increased by 42% drntngthe second minute of recovery following creatine
supplementation, a finding that suggests a shorter work to rest ratio may also enhance
performance. Another purpose of this study, therefore, was to compare the effects of
recovery time on power output during repeated bouts of high intensity exercise following
creatine supplementation.
Scope of Problem
Fourteen male cyclists (18-40 y) served as subjects to test the effects of oral
creatine monohydrate supplementation on recovery time during repeated bouts of high
intensity cycling.
Problem Statement
The effects of creatine monohydrate supplementation on power output during
repeated bouts of supramaximal cycling was studied in trained cyclists.
Hwothesis
1. Following creatine supplementation subjects will exhibit greater peak power output
and less fatigue across repeated bouts of high intensity cycling compared to placebo
subjects.
2. Creatine supplemented subjects will have greater resistance to fatigue during high-
intensity exercise compared to placebo subjects.
4cycling with a recovery period of 9O-seconds, but not with recovery periods of 45 or
135 seconds.
Assumptions
The following assumptions applied to this study.
1. The subjects followed the supplement regimen as prescribed.
2. The subjects participated at their maximum ability during testing sessions.
3. The subjects followed pretesting instructions.
4. The subjects did not take other ergogenic aids during the study.
5. The subjects did not alter their training or dietary habits.
Definition of Terms
The following terms were operationally defined for the purpose of this study.
l. Repeated Bouts of Supra-maximal Cycling: Bouts of cycling using a
predetermined load of 5.5%o of body weight at which the subject was asked to give a
maximal effort for a 45 second cycling period. The bouts were repeated four times, each
intemrpted by an active rest period.
2. Active Rest Period: A period of minimal activity between cycling bouts that
ranged from 45 to 135 seconds during which the subjects maintained 70-80 rpms to
recover from their rnaximal effort.
Delimitatiolls
The delimitations of this study were as follows:
1. Only trained male cyclists between the ages of 18-40 y were tested, therefore
these results may not be generalizable to other ages or fernales.
2. Creatine supplementation was generally less than 30 days, and therefore these
results may not apply to those supplemented for longer periods of time.
Limitations
The limitations of the study were as follows:
l. Muscle biopsies were not taken from the subjects to determine baseline or
post-supplementation muscle creatine levels.
2. Subjects were not tested on their own bicycles. This may have affected
performance due to comfort level and/or psychological stress.
Chapter 2
REVIEW OF LITERATURE
Introduction
Creatine, or methylguanidine-acetic acid, is an amino acid that was first identified
in 1832 by Chevreul (Balsom, Soderlund, & Ekblom, 1994;Zoeller & Angelopoulos,
1998). Creatine, which is mainly formed in the liver, is composed of three amino acids.
arginine, methionine, and glycine. After synthesis, creatine is actively transported into
many cells via a specific transport protein using the energy contained in the sodium
gradient. This transport protein has a high affinity for creatine and concentrates it within
the cell. Once in the cell, most creatine stays there, as the cell loses < 3o/o per day. The
majority of creatine lost is excreted in the urine in the form of creatinine. Daily turnover
of creatine to creatinine for a 70 kg male is approximately 2 g (Balsom et al., 1994).
In addition to the endogenous formation of creatine, the average daily diet
supplies I g, mainly from the consumption of meat and fish (Englehardt, Neumann,
Berbalk & Reuter, 1998). Collectively, the endogenous and exogenous sources of
creatine sustain a plasma creatine concentration of 40 to 100 zmol L-t; lower values of 25
to32umol'L-t are sustained in vegetarians @nglehardt et al., 1998).
In humans, over 95Yo of total body creatine is in the skeletal muscle. Approximately one-
third of this muscle creatine is in the free form. whereas the remaining amount is
phosphorylated (PCr). Creatine levels in human skeletal muscle are
7subject to individual variations including such factors as muscle fiber t1pe, age, and
disease (Balsom et al., lgg4). Fast twitch or type II fibers, for example, have more
creatine than slow twitch or type I fibers (Englehardt et al., 1998).
ATP Depletion
The energy needed to rephosphorylate ADP to ATP after exercise is supplied by
muscle PCr in a I :1 ratio: one molecule of PCr is needed to rephosphorylate one
molecule of ADP. As PCr stores are depleted, perforrnance deteriorates because of the
inability to resynthesize ATP at the required rate. Brief bouts of high intensity exercise
increase the ATP demand in the working muscles to several hundred-fold above resting
values. In humans, for example, the rate of ATP turnover in dry muscle is approximately
6 mmol'kg-r's-r during 25 seconds of electrical stimulation of the quadriceps and between
13 and 15 mmolkg-''s-t during 6 to 10 seconds of all out cycling. These data show that
high intensity exercise can deplete PCr stores within 10 seconds based on normal total
muscle creatine concentrations of 130 to 150 mmolkg-' of dry muscle (Balsom et al.,
te94).
PCr Resynthesis
The resynthesis of PCr in human skeletal muscle is an oxygen dependent process
composed of a fast and slow component (Haff& Potteiger, 1997). Following the
completion of high intensity exercise, approximately half the PCr content is restored
within one minute of recovery (fast component), and total creatine resynthesis is nearly
complete after approximately five minutes (slow component) (Balsom et al., 1994). The
initial rate of resynthesis is fastest in type I fibers, which may be linked to their enhanced
oxidative capacity. Increasing muscle creatine content may accelerate the rate of PCr
resynthesis during high intensity, short duration exercise bouts (Kreider et al., 1997). For
example, Greenhaffetal. (1994) found that creatine supplementation improved the rate
of PCr resynthesis by approximately 42o/o during the second minute of recovery after
electrically evoked isometric contraction of the vastus lateralis.
Effect of Creatine Supplementation on Performance
Many studies have examined the effect of creatine supplementation on muscle
performance. These studies are separated into two broad categories to better otganize
this review: non-cycling and cycling related studies. In the non-cycling studies, creatine
supplementation increased the amount of work completed during five bouts of 30
maximal voluntary knee extensions, with each bout separated by 60 seconds of passive
rest (Greenhaff, Bodin, Soderlund, & Hulftnan, 1993). Similarly, creatine ingestion led
to better maintenance of target speed, and hence, increased total work during 10 repeated
six second bouts of maximal exercise that were separated by 30 seconds of passive
recovery (Balsom et al., 1993). Creatine ingestion also increased the amount of work
completed by elite kayakers during 90 seconds, 150 seconds, and 300 seconds of kayak
ergometry and by weight lifters during five sets of bench press at a fixed load
(McNaughton, Dalton, &Tarr,1998; Volek et al., 1997). Aside from improving total
work, creatine ingestion increased peak strength, measured by one repetition maximum
bench press, and a set of five jump squats (Earnest et al., 1997; Volek et al., 1997).
9As with the aforementioned non-cycling studies, creatine ingestion also enhanced
muscular performance during cycling activities, typically measured with the cycle
ergometer. Several studies show that creatine ingestion improves total work, and in some
cases, peak power output during repeated 30 second bouts of cycling (Casey et al., 1997;
Earnest et al., 1997; Birch et al., 1994). The mean increase in total work across the
studies was approximately 8%o,butit did vary widely. In one study total work increased
by approximately 16%o during a series of three consecutive 30 second Wingate tests
separated by five minutes of rest (Earnest et a1., 1997). In the other two studies, total
work only increased by about 4%o duing three, 30 second bouts of maximal isokinetic
cycling separated by four minutes of passive recovery (Birch et al., 1994), or two, 30
second Wingate tests separated by four minutes of passive rest (Casey et a1., 1996). In
these latter two sfudies, peak power output also increased by about 5o/o after creatine
supplementation.
As with 30 second cycling bouts, creatine ingestion also improved performance
during short repeated bouts of cycle ergomety. Total work during the first half of 12, six
second sprints separated by 30 seconds of rest increased by nearly 5lo/o aftercreatine
ingestion (Kreider et a1., lggl). Similarly, creatine supplementation reduced fatigue by
28Yo duing a 10 second sprint, indicated by maintenance of higher pedaling frequency
(Balsom et a1., 1995).
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Mechanism for Improved Performance
The ergogenic effect of creatine supplementation is possibly due to an increase in
the skeletal muscle's ability to sustain ADP phosphorylation during exercise. This
enhanced ability to sustain ADP phosphorylation may be the result of increased pre-
exercising PCr availability, an improved buffering capacity, or an accelerated rate of PCr
resynthesis during exercise and recovery, or some combination of these factors (Casey et
al., 1996). The most widely touted mechanism combines several of the aforementioned
scenarios. In short, creatine ingestion increases muscle creatine content, thereby
accelerating PCr resynthesis between exercise bouts. As a result, the required rate of
ADP phosphorylation is sustained longer after supplementation (Balsom et al., 1994;
Brannon, Adams, Conniff, & Baldwin,1997; Earnest et al., 19971' Greenhaff etal.,1994).
Creatine supplementation, for example, has been shown to accelerate PCr resynthesis
during recovery from intense electrically evoked isometric muscle contractions in man
(Greenhaffet a1., 1994). Similarly, creatine ingestion reduced muscle ATP loss by 30%
after two Wingate tests separated by four minutes of recovery, suggesting that ADP
phosphorylation was improved by supplementation (Casey et al., 1996).
Lack of Ergogenic Effect
Not all experiments, however, found that creatine supplementation improved
performance, even if supplementation increased muscle total creatine content (TCr)
(Balsom, Harridge, Soderlund, Sjodin, & Ekblom, 1993; Greenhaff, Bodin, Ha.rris,
Hultrnan, Jones, Mclntyre, Soderlund, & Turner 1993; Odland, Macdougall,
ll
Tarnopolsky, Elorriag4 & Borgmann,1997; Terrillion, Kolkhorst, Dolgner, & Joslyn,
lggT). Two factors that may account for this negative result are the nature of the work
bout and the subjects' initial muscle TCr level. Creatine ingestion, for example, did not
affect performance if the work or test bout was longer than 30 seconds, i.e., if it required
a significant contribution from the aerobic metabolic pathways of ATP production
(Dawson et al., 1995; Febbraio, Flanagan, Snow, Zhao, & Carey, 1995; Balsom et al.,
1993). Similarly, creatine supplernentation had no effect on single bouts of 30 second
exercise (Odland et al., 1997; Ruden et al., 1996). In contrast, creatine ingestion did
improve performance when the work bout was less than 30 seconds and it was performed
at least twice (Bosco, Tihanyi, Pupcspk, Kovacs, Gabossy, Pulvirenti, Tranquilli, Foti,
Viru, & Viru, 1997; Brannon et al., 1997; Earnest et al., 1997; Harris, Viru, Greenhaff, &
Hultman, 1993; Kreider et al., 1997; Volek, Kraemer, Bush, Boetes, Incledon, Clark, &
Lynch, 1997). Thus, the effectiveness of creatine zupplementation is most evident during
short-term, high intensity activities that involve repeated efforts interspersed with
sufficient recovery time to permit PCr resynthesis (Earnest et al., 1997).
Another possible explanation for the discrepancies among studies is the subjects'
initial muscle creatine concentration. Recent data reveal that the mean skeletal muscle
creatine concentration is 125 mmol per kgof dry muscle (dm), with a normal range
between 90 and 160 mmol per kg dm (Balsom et al., 1994). Additional data show that a
TCr increase of >20 mmol per kg dm or about 8%o is required to improve pcr
resynthesis, and hence, exercise performance (Casey et al., 1996; Englehardt et al., 1998;
t2
Green et al., 1996;Greenhaffet a1.,1994). The wide range for skeletal muscle creatine
concentration and the magnitude of the increase needed to increase performance may
explain why some, but not all studies have shown the ergogenicity of creatine
supplementation. In one study, for example, approximately half the subjects had pre-
freatrnent creatine concentrations of < 125 mmole per kg drn (vegetarians had the lowest
values). After supplementation, those individuals with the lowest TCr values exhibited
the greatest increase in muscle creatine concentration, PCr regeneration, and performance
(Greenhaffet a1., 1994). In contrast, subjects with baseline creatine levels near the
physiologic maximum, did not respond to creatine supplementation, as muscle creatine
levels could not be increased by the required 8% (Clark, 1997). Individuals with such
high baseline values are classified as "nonresponders", and may represent nearly 30o/o of
most subject cohorts (Clark, 1997).
Summary
Creatine is an amino acid compound that exists in skeletal muscle and provides
the body with a source of anaerobic energy. The creatine phosphate system fuels muscle
contraction during short duration, high-intensity exercise that lasts 10-15 seconds.
Creatine supplernentation can increase TCr and PCr stores 10-20% and20-40%o,
respectively. In addition, creatine supplementation enhances short duration, high-
intensity exercise performance, possibly by increasing ATP production, or accelerating
the rate of PCr resynthesis during and following the bouts of exercise. Supplementation
seems to be most effective in enhancing performance in work to rest ratios of l: 5 or
13
greater. Creatine supplementation will not augment performance for individuals with
high pre-existing creatine stores; supplernentation will also not enhance endurance
performance.
Chapter 3
METHODS
Subjects
Fourteen trained male cyclists (age range 18-40 y) were recruited. AII subjects
had a minimum of two years of competitive cycling experience which included racing no
less than six times per year. Each subject was informed of the risks associated with the
procedures, and signed a letter of informed consent prior to participation. The Human
Subjects Review Committee at Ithaca College approved all procedures.
Procedures
Subjects were tested on five occasions, each separated by at least three days of
rest. The tests included a: l) Wingate anaerobic power test, 2) maximal oxygen
consumption test, 3) recovery test 1, 4) recovery test2, and 5) recovery test 3. A
mechanically braked cycle ergometer (Monark 8184 Monark Cotp., Sweden) that was
modified with an Instaload Friction Belt (Sports Medicine Industries, Inc., St. Cloud,
MN), racing saddle, drop handlebars, and the subject's pedal system was used in all tests.
The saddle height on the ergometer was adjusted to produce a 10 degree knee angle at
full leg extension. All tests were preceded by a three hour fast and 10 minutes of cycling
at200 W; each test was also followed by 5 minutes of cycling against minimal resistance.
Subjects were also instructed to refrain from strenuous physical activity during the24
hours that preceded a test.
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Wingate Anaerobic Power Test
On test day one, subjects completed a Wingate anaerobic power test.
Immediately prior to the test, the subject was given a five second count, during which he
tried to obtain his maximal cadence. At zero seconds, the test began when a load
equivalent to 7 .syoof the cyclist's body mass was applied as resistance. The subject
remained seated and was given vigorous verbal encouragement during the test (Bar-Or,
1987). Mean, maximurn, and minimum power, as well as percent fatigue, were recorded
with the Optisensor 2000 (Sports Medicine Industries, Inc., St. Cloud, MN) linked to a
computer.
Maximum Oxygen Consumption
On test day two subjects completed a continuous exercise protocol to determine
maximum oxygen consumption (VO2max). The initial workload was 200 W and was
increased 40 W every two minutes until the prescribed cadence of 80 + 3 RPM could not
be maintained. Oxygen consumption was measured using open circuit spirometry with a
computerized metabolic cart (SensorMedics 2900, Yorba, Linda CA) and heart rate via
telemetry (Polar Instruments Inc., Oulu, Finland). Perceived exertion was obtained at the
end of each two-minute stage using the Borg scale (Borg, 1957). Five minutes prior to,
and three minutes following the VOzmax test, a25 ul blood sample was drawn from the
fingertip and analyzed for lactate concentration (YSI 1500 Sport Tester, Yellow Springs,
oH)
l6
Recoverv Test Protocol
Three days prior to the first recovery test, subjects were famil iaizedwith the
procedures by completing three maximum,45 second exercise bouts separated by 45
seconds of low intensity active recovery. The familiarization test was conducted to
minimize any Iearning effects associated with the protocol. In the recovery tests, subjects
completed four bouts of high intensity cycling separated by a brief period of active
recovery of either 45,g}or 135 seconds. Only one recovery period was used on a given
test day. The order of the recovery periods was assigned randomly to minimize possible
learning and training effects. The high intensity cycling bouts were completed in the
same fashion as the Wingate test except the bout was 45 seconds and the resistance was
5.5% of body mass. The resistance for the active recovery period was2.5%o of body mass
and pedal frequency was 80 rpm. The resistance levels were derived from a pilot study
(N: 5), which determined a higher resistance level did not allow the subjects to complete
all four cycling bouts. During all tests, heart rate, VO2, work, and power output were
measured as previously described. Percent fatigue was measured within each 45 second
work bout, and across bouts I and 4. In addition ,25 ulblood samples were obtained five
minutes prior to, immediately following the second supramaximal exercise bout, and
three minutes following the fourth bout to determine blood lactate concentration as
previously described.
t7
Creatine Administration
After the VOzmzx test, subjects were randomly assigned to a creatine (Cr) or
placebo condition. A double-blind protocol was used. The Cr group consumed creatine
(phosphagen HP, Experimental and Applied Sciences Co., Golden CO.) and the placebo
group consumed a Phosphagen HP placebo. Subjects supplemented in two phases.
During the first phase, or the loading phase, both groups were instructed to consume 5 g
of product, five times a day for five days. Each 5 g dose was dissolved in 1000 ml of
warm water and taken at regular intervals during the day. After the loading phase, the
subjects began the maintenance phase, in which they consumed 5 g of product daily until
the last day of testing (about 4 weeks). The amount of creatine consumed has been
shown to increase and maintain intramuscular TCr stores (Greenhaff et al., 1994l, Harris
et al., 1992).
Supplement packets were administered in coded boxes containing a five-day
supply of product. Supplementation for either phase was verified by having the subjects
return the empty product packets. No subject began the maintenance phase without fully
completing the loading phase. Subjects were asked to maintain their normal diet and to
avoid any other nutritional supplements, proposed ergogenic aids, and nonprescriptive
drugs during the course of the study.
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Blood Sampling
On test day 2(VOrmax test) a 25 ulbloodsample was drawn from the fingertip(s)
five minutes prior to, and three minutes following the cycle test for determination of
blood lactate concenkation. On test days 3 to 5, 25 zl blood samples were obtained five
minutes prior to, immediately following the second supramaximal exercise bout, and
three minutes following the fourth bout to determine blood lactate concentration.
Urinarv Creatinine Excretion Analvsis.
Urinary creatinine excretion was measured following completion.of the loading
phase so that loading could be further verified. A 24 hour urine sample was collected
from each subject. Urinary creatinine level was measured with a colometric analysis
developed by Sigma Diagnostics (Sigma Diagnostics, Inc. St. Louis MO).
Statistical Analvses
A three-way repeated measures analysis of variance (ANOVA) for groups (2),
recovery period (3), and exercise bout (4) was used to analyze the dependent variables of
peak power, mean power, blood lactate, percent fatigue, H& and VO2. Simple main
effects were evaluated with a post-hoc Tukey HSD. Descriptive statistics included
anaerobic power, VOzrIl&X, years of training, age, height, and weight.
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Chapter 4
RESEARCH MANUSCRIPT
INTRODUCTION
The ability of creatine zupplementation to enhance cycling performance is shown
by studies that report improved power output during short, repeated bouts of high
intensity cycling (Balsom et al., 1995 Balsom et al., 1993- Birch et al., 1994; Casey,
Constantin-Teodosiu, Howell, Hultman, & Greenhafl 1996; Dawson, Cutler, Moody,
Lawrence, Goodmaq & Randall, 1995; Earnest et al, 1997; Kreider et al., 1997). The
extension of these findings to the competitive cycling arena, however, is limited by
several factors. First, none of the zubjects in the aforementioned studies were trained
cyclists. Second, passive rather than active recovery was used in these studies; the
opportunity for passive recovery rarely occurs during competitive road cycling. Another
factor that limits the applicability of these studies to the competitive arena is the short
duration of the cycling bouts, which lasted for less than l0 seconds in several studies
(Balsom et al., 1993;Balsom et al., 1995; Kreider et aL, 1997). In road racing, cyclists
often perform several consecutive 30 to 60 second high intensity efforts during a series of
attacks or for the final sprint set-up. Thus, it remains to be seen if creatine
supplementation benefits a trained cyclist in a more applied setting. Hence, one purpose
of this study was to determine if creatine supplementation improves performance in
trained cyclists who complete repeated bouts of high intensity cycling of a length more
characteristic of the sport.
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Whereas the ability of creatine to increase power output during repeated bouts of
high intensity exercise is well documented, there is little information on the minimum
recovery time needed between work bouts to maintain power output. A work to rest ratio
of l:5 has been used in many studies (Balsom et a1., 1993; Balsom et al., 1995; Birch et
al.,1994;Earnest et al., 1997;Kreider et al., lgg7). However, a shorter work to rest ratio
of l:2 was used by Greenhaffet al. (1993). They demonstrated that PCr resynthesis was
increased by 42% during the second minute of recovery following creatine
supplementation, a finding that suggests a shorter work to rest ratio may also enhance
performance. Therefore, another purpose of this study was to compare the effects of
recovery time on power output during repeated bouts of high intensity exercise following
creatine supplementation.
METHODS
Subjects. Fourteen trained male cyclists (age range l8-40 y) were recruited (Appendix
E). physical and training characteristics are presented in Table l. All subjects had a
minimum of trvo years of competitive cycling experience (Appendix A). Each subject
was informed of the risks associated with the procedures, and signed a letter of informed
consent prior to participation (Appendices B, C). The Human Subjects Review
Committee at Ithaca College approved all procedures.
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Procedures. Subjects were tested on five occasions, each separated by at least three days
of rest. The tests included a: 1) Wingate anaerobic power test, 2) maximal oxygen
consumption test, 3) recovery test 1, 4) recovery test 2, and 5) recovery test 3. A
mechanically braked cycle ergometer (Monark 8184 Monark Corp., Sweden) modified
with an Instaload Friction Belt (Sports Medicine lndustries, Inc., St. Cloud, MN), racing
saddle, drop handlebars, and the subject's pedal systern was used in all tests. The saddle
height on the ergometer was adjusted to produce a l0 degree knee angle at fulIleg
extension. All tests were preceded by a three-hour fast and l0 minutes of cycling at2o0
W; each test was also followed by 5 minutes of cycling against minimal resistance.
Subjects were instructed to refrain from strenuous physical activity during the24 hours
that preceded a test.
Wingate Anaerobic Power Test. On test day one, subjects completed a Wingate
anaerobic power test. At zero seconds, the test began at a load equivalent to 7.5o/o of
body mass (Bar-Or, 1987). Mean, maximum and minimum power, as well as perient
fatigue, were recorded (Appendix D) with the Optisensor 2000 (Sports Medicine
Industries,Inc., St. Cloud, MN) linked to a computer.
Maximum Oxygen Consumption. On test day two subjects completed a continuous
exercise protocol to determine maximum oxygen consumption (VO2max). The initial
workload was 200 W and was increased 40 W every two minutes until the prescribed
cadence of 80 + 3 RPM could not be maintained (Appendix D). Oxygen consumption
was measured using open circuit spirometry with a computerized metabolic cart
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(SensorMedics 2900, Yorba, Linda CA) and heart rate via telemetry (Polar Instruments
Inc., Oulu, Finland). Perceived exertion was obtained at the end of each two-minute
stage using the Borg scale (Borg, 1957). Five minutes prior to, and three minutes
following the VOzmax test, a 25 zl blood sample was drawn from the fingertip and
analyzed for lactate concentration (YSI 1500 Sport Tester, Yellow Springs, OH).
Recovery Test Protocol. Three days prior to the first recovery test, subjects were
familiarized with the procedures by completing three maximum, 45 second exercise bouts
separated by 45 seconds of low intensity active recovery. In the recovery tests, subjects
completed four bouts of high intensity cycling separated by a brief period of active
recovery of either 45,90 or 135 seconds. Only one recovery period was used on a given
test day. The high intensity cycling bout was 45 seconds and the resistance was 5.5% of
body mass. The resistance for the active recovery period was 2.5%o of body mass and
pedal frequency was 80 rpm. The resistance levels were derived from a pilot study (N:
5), which determined a higher resistance level did not allow the subjects to complete all
four cycling bouts. During all tests, heart rate, VO2, work, blood lactate, and power
output were measured as previously described. Percent fatigue was measured within
each 45 second work bout, and across bouts 1 to 4 (Appendix D).
Creatine Administration. After the VOzmax test, subjects were randomly assigned to a
Cr or placebo condition. A double-blind protocol was used. The Cr group consumed
creatine (Phosphagen HP, Experimental and Applied Sciences Co., Golden CO.) and the
placebo group consumed a Phosphagen HP placebo. Subjects supplemented in two
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phases. During the first phase, or the loading phase, both groups were instucted to
consume 5 g of product, five times aday for five days. After the loading phase, the
subjects began the maintenance phase, in which they consumed 5 g of product daily until
the last day of testing (about 4 weeks). The amount of creatine consumed has been
shown to increase and maintain intamuscular TCr stores (Greenhaff et al., 1994; Harris
et al., 1992).
Supplernent packets were administered in coded boxes containing a five-day
supply of product. Supplementation for either phase was verified by having the subjects
return the empty product packets. No subject began the maintenance phase without fully
completing the loading phase. Subjects were asked to maintain their normal diet and to
avoid any other nufitional supplements, proposed ergogenic aids, and nonprescriptive
drugs during the course of the study.
Urinary Creatinine Excretion Analysis. Urinary creatinine excretion was measured
following completion of the loading phase so that loading could be further verified. A
creatinine kit designed by Sigma Diagnostic Laboratories was utilized to measure urinary
creatinine excretion over a 24 hour period (Sigma Diagnostics, Inc. St. Louis MO).
Statisticat Analyses. A three-way repeated measwes analysis of variance (ANOVA) for
groups (2), recovery period (3), and exercise bout (4) was used to analyze the dependent
variables of peak power, mean power, blood lactate, percent fatigue, HR, and VOz.
Simple main effects were evaluated with a post-hoc Tukey HSD. Descriptive statistics
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included anaerobic power, VO2max, years of training, age, height, and weight. ANOVA
tables appear in Appendix D, and raw data in Appendix E.
RESULTS
Peak Power Output. Peak power output for each 45 second cycling interval was
measured and calculated as the average power output for the first five seconds of each
bout. As shown in Table 2 and Figure l, there was no significant difference in peak
power output between groups or recovery tests (p>0.05). As expected there was an llYo
decrease in peak power output across bouts (p>0.05).
Mean Power Outpul Mean power output was measured during each cycling bout and
calculated as the average power output during the entire 45 second bout. As shown in
Table 3 and Figure 2, there was no significant difference in mean power output between
groups or recovery tests (p>0 05). Mean power decreased lYo across four bouts (p<0.05).
Percent Fatigue. Percent fatigue was measured for each 45 second cycling bout and
across bouts 1 and 4 for each recovery test. On average the Cr and placebo group showed
a23%o decrease in power output. As shown in Figure 3, there was no difference between
the two groups for any cycling bout or recovery test.
Blood Lactate. In the recovery tests, blood lactate concentration was measured pre-
exercise, immediately post cycling bout 2, and three minutes after exercise bout 4. A
three-way ANOVA analyses revealed a significant difference (p<0.05) for this variable.
Subsequent post-hoc analyses showed that the Cr group had a lower blood lactate
concentration after bout 2 as shown in Table 4 and Figure 4. There were no other
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differences in blood lactate concentration for this study.
Body Mass, Heart Rate, and Oxygen Consumption. There were no significant
differences in body mass across time or between groups during the study, although the Cr
group did gain 3.5o/o more mass compared to the placebo group. As shown in Tables 5
and 6, there were no differences in HR or VOz between groups or recovery tests (p>0.05).
Creatinine Excretion. Urinary creatinine excretion was measured over a 24hotx period.
The sample was collected from all subjects immediately upon completion of the five day
loading phase of supplementation. Mean urinary volume was 1843 ml and not different
between groups. The Cr group had a g2Yohrgher creatinine excretion than the placebo
group (p < 0.05).
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Tablc l
Physical and Training Charact
Variable
Group
P-value
Aee (v)
Years Training
weight (kg)
pre
post
Height (cm)
Body Fat%o^
pre
post
Fat Free Mass (kg)
pre
post
Anaerobic Power (W)
VO2 max (ml.kg.-tmin t)
25。2■5。92
7.3±4。60
72.4±8.10
72.1 ■8.32
169.4±9.54
9。1 ±4.09
9.7±4.28
66。2±9.04
65.8 ± 9.59
887.6 ±89。75
61.5 ±4.70
22.7 ± 4.86   。105
4.2 ± 2.89   。138
70.1 ■ 9.48   .203
70.6 ■ 9。85   .187
169.6 ± 9.02   .124
9.0 ± 3.59   。165
8.7 ± 3.86   .159
64.9 ± 9.87   .185
64。3 ■ 9.95   .181
887.8 ±99.50   .093
58.7 ■ 5.00   .107
Note.' Body fato/o calculated using a seven site skinfold test (Jackson & Pollock, 1985).
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Cycling Bout
Fiqure 1. Peak power (mean t SEM) for groups during four bouts of 45-sec
supramaximal rycling exercise. Subjects cycled maximally at 5.506 of body weight during
each bout. Repeated bouts were separated by an adive recovery period in which subjecls
cycled at 70-80 rpm at 2.5o/o of body weight. The active recovery periods were 45,
90, and 135 seconds. # = bout 1 greater than bouts 2,3, & 4 in both groups (p < 0.05).
* 
= bout 2 greater than bouts 3 & 4 in both groups (p < 0.05).
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Cycilng Bout
Fiqure 2. Mean power (mean t SEM) for groups during four bouts of 4$sec
supramaximal cycling exercise. Subjects cycled maximally at 5.5% of body weight during
each bout. Repeated bouts were separated by an active recovery period in which subjects
cycled at 70-80 rpm at 2.5o/o of body weight. The active recovery periods were 45,
90, and 135 seconds. # = bout 1 greater than bouts 2,3, & 4 in both groups (p < 0.05).
* 
= bout 2 greater than bouts 3 & 4 in both groups (p < 0.05).
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Figure 3. Fatigue (mean t SEM) during four bouts of 45-sec supramaximal cycling
exercise. Repeated bouts were separated by an active recovery period, during which
subjects maintained 7G80 rpm at2.50fo of body weight. Fatigue was calculated as
the ((hig hest-lovrrest mean power)/h ighest) X1 00.
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Fioure 4. Blood lactate (mean t SEM) for groups during four bouts of 45-sec
cycling exercise. Measurements were taken five minutes beforc cycling
began, supramaximal immediately post bout 2, and three minutes after
completion of bout 4. * = significant difference between Cr and placebo
(p < 0.05).
|=盤|
4t
DISCUSSION
The primary purpose of this study was to determine if creatine supplementation
affects recovery time during repeated bouts of high intensity cycling. To that end, well
trained cyclists completed four, 45 second supramaximal cycling intervals separated by
45 seconds, 90 seconds or 135 seconds of active r@overy, thereby yielding workto rest
ratios of: I : l, l:2, and l:3. This experimental design also permitted examination of the
potential benefit of creatine supplementation to trained road cyclists, as the length of the
lab test (a5 s) was more characteristic of actual road racing than tlpically studied test
durations of 6-10 seconds.
Data from this study show that there were no significant differences in peak or
mean power between the groups for any work to rest ratio. These data are consistent with
findings from several studies @alsom et aI., 1993; Dawsorq Cutler, Moody, Lawrence,
Goodman, & Randall, 1995; Febbraio, Flanagaq Snow, Zhao, & Carey,1995), but
conflict with data from many other studies @alsonq Ekbolm, Soderlund, SjodirL &
Hultmaq 1993b;Bircb Noble, & Greenhaff,l994;Earnest, Snell, Rodriguez, Almadq &
Mitchell; Harris, Soderlund, & Hultman, 1997;Zoeller, & Angelopoulos, 1998).
Creatine zupplementation also did not change the rate of fatigue across each exercise
bout or from bouts one to four for all recovery tests. These data are inconsistent with the
data from other studies that show creatine supplementation decreases fatigue during short
duration high-intensity exercise @alsonr, Ekbolm, Soderlund, SjodirL & Hultman,1993;
Birch et d,.,1994; Earnest et al., 1997).
|
The length of the work to rest ratio may partially explain the discrepancy in the
data from the aforementioned studies in which repeated work bouts were used to
determine the effect of creatine on power output and fatigue. In most studies that show
creatine enhances power output or decreases fatigue during repeated bouts of high
intensity exercise, the work to rest ratio is longer than l:5 @alsom et al., 1993; Balsom et
al., 1995; Birch et a1.,199{ Earnest et al., 1997; Kreider et al., 1997). One exception is
the l:2 workto rest rutio used by Greenhaffet al. (1993), whose data prompted the use of
an even shorter work to rest ratio in this study. Since creatine supplementation had no
effect on power output or fatigue in this study, but did so in studies with longer work to
rest ratios, it is possible that the ratios in the present study were too short to show
ergogenicity of creatine.
The results from this study may differ due to the nature of the work bout. In
previous worlg creatine supplementation did not improve performance when either a
single work bout or multiple bouts longer than one minute were used (Febbraio et al.,
1995; Balsom et al., 1993; Odland et al., 1997; Ruden et al., 1996). In contrast, creatine
supplementation did enhance performance with repeated work bouts of less than 30
seconds (Balsom et al., 1995; Balsom et al., 1993; Birch et al., 1994; Casey et al., 1996;
Dawson et al., 1995; Earnest et al., 1997; Kreider et al., 1997)- Thus, the effect of
creatine supplementation is best shown with repeated short-term bouts (30 seconds or
less) of high intensity activity that are separated by suffrcient recovery time. These are
activities in which aerobic ATP contribution is minimal (Earnest et al., 1997). Since
creatine supplementation did not affect power output or fatigue in this study, it is possible
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that the repeated 45 second work bouts were too long and required too much
aerobic ATP production to benefit from the potential ergogenicity of creatine.
An initial difference in intramuscular creatine stores is another factor that may
partially explain why creatine supplementation did not alter performance. If a subject
cohort contained a high number of individuals with baseline intramuscular creatine levels
near the physiologic maximum of 160 mmol'kg-r of dry muscle, the effect of creatine
would be reduced. Such individuats are non-responders because their intramuscular
creatine stores are not sufficiently eleVated by creatine supplementation (Clarlq 1997).
Non-responders, moreover, typically represent 30% of most zubject cohorts (Cla&
lg97). The subject cohort in this study may hive contained a high percentage of non-
responders, as there was no significant change in body mass across time in the Cr group
which is typically observed following creatine loading (Balsor4 Ekbolm, Soderlund,
Sjodin, & Hultmaq 1993;BalsonL Harridge, Soderlund, Sjodin, & Ekbol4 1993;
Earnest, Snell, Rodriguez, Almadq & Mitchell; Harris, Soderlund, & Hultman, 1992;
Voleh Kraemer, Bus[ Boetes, Incledon, Clarh & Lynctr, 1997).
Failure to consume the prescribed amount of creatine could also explain the lack
of effect in the Cr group. The dosage was derived from studies in which creatine
supplementation effectively enhanced performance @alsom et aI., 1994). The possibility
of subject non-compliance is remote, however, as each packet of creatine was refurned
emptied and subjects self reported supplementation adherence. In addition, analysis of
the post-loading creatinine data demonstrated that creatine uptake was maximized,
suggesting full intramuscular stores. Unfortunately, muscle creatine levels were not
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directly measured in this study. These creatinine data" however, are consistent with data
reported elsewhere, in which the muscle creatine level was also measured to confirm
creatine uptake (Greenhaffet al., 1993; Harris, Soderlund & Hultman,1992).
ln contrast to the power and fatigue data, creatine supplementation altered lactate
accumulation, but only after bout 2 in the 45 second recovery tests. The decrease in
lactate after bout 2 in the 45 second r@overy tests may have been due to increased
muscle creatine levels. If muscle creatine is increased, energy release from the creatine
phosphate energy cycle could have been maintained longer, thereby attenuating the
increase in glycolysis, and subsequently, blood lactate. The lack of a significant
differenoe in lactate after bout 4 in the 45 second tests and in the other tests may be due
to the duration of the work and recovery periods. If the cycling bouts were shorter, this
would decrease the necessary anaerobic and aerobic contributions to muscle energetics.
Likewise, if the recovery periods were longer, PCr resynthesis would be enhanced. In
either case, creatine supplementation could have altered lactate more consistently across
all measurement periods and recovery tests. For example, creatine supplementation
significantly alters blood lac,ate during l0 second work bouts @alsom et al., 1995). In
contrast, the significant decrease in lactate after bout 2 in the 45 second recovery test may
not have been a result of creatine supplementation. Instead, it is possible that muscle
lactate was not cleared sufiiciently after bout 2inthe 45 second recovery tests, and
elevated blood lactate. If so, this might explain why there was no difference between the
groups after bout 4 in the 45 second remvery tests.
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Summary. tn conclusion, these results indicate that creatine supplementation did
not enhance peak or mean power production during repeated supramaximal cycling
bouts. In additiorL creatine toading did not favorably alter I{R, VOz, or the rate of
fatigue. Based on these dat4 creatine supplementation is not indicated for high intensity
activities that are 45 seconds in duration or longer.
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Name:
Appendix A
CREATINE SUPPLEMENTATION QUESTIONNAIRE
Age:
Local Address:
Local Phone:
Birth Date:
E―mail:
Sex:M/F Weight(lbs.):
How long have you been cycling consistently?.
How many days per week do you ride?  Less than 2        2-4        4-7
What percentage of your cycling is? Sprinting 
- 
Distance
Mountain Biking
On average, how many miles per week do you ride?
How many caffeinated beverages do you consume daily?
Have you used any form of creatine supplementation within the last six months? Yes / No
If so, when did you stop taking the supplement?
Are you currently taking any other form of ergogenic aid, legal or illegal? Yes / No
Are you a vegetarian? Yes / No
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Appendix B
INFORMED CONSENT FORM
Elfects of creatine supplementation on power output during repeated bouts of supra-
maximal cycling.
1. Purpose of the study:
The purpose of this study is to investigate the effects of oral creatine monohydrate
on recovery from repeated bouts of supra-maximal cycling.
2. Benefits of the study:
By participating in the study you will learn if creatine monohydrate actually
enhances cycling performance. You will also learn your VO2 mtrx, the best single
predictor of a person's work capacity. This knowledge can be very valuable for training
in the most efficient manner.
3. Your Participation Requires:
You will report to the laboratory for 6 days. Days I &22 Onthe first 2 days you
will become familiarized with the equipment and testing protocol. Day 3: The third day
you will complete a VOz max test, which requires about 8-15 minutes of cycling. tn this
test you will pedal a cycle ergometer until volitional fatigue, and you will wear a
headgear device with a 2-way breathing valve so that we can measure your expired gases.
After the third test day you will take a supplement 5 times per day for 5 days, then one
time per day until the last test day (approximately 4 weeks). Days 4-6: On the following
three test days, after supplonentation, you will ride a cycle ergometer at maximum
intensity for 4 repeated bouts lasting 45 seconds. The repeated bouts of maximum effort
cycling will be intemrpted by active recovery intervals between 45-135 second long.
Recovery time following each bout of exercise will be the same on each test day but will
vary between 45, 90, and 135 seconds. On test day 3 (VO2 max) a small (25 ul) blood
sample will be drawn from the fingertip(s) l0 minutes prior to and immediately following
the second cycle test and analyzed for blood lactate concentration. On days 4-6, blood
samples (25 ul) will be obtained l0 minutes prior to, following the second supramaximal
exercise bout, and immediately following the testing to determine blood lactate
concentration. Each test session will be 30-60 minutes long.
4. Risks of participation:
The risks associated with this test protocol are minimal. For maximal exercise
testing in a healthy population the ACSM has recorded one event per 187,500 hours of
testing, and one death per 396,000 hours of testing. This figure includes individuals who
are trained as well as untrained. There is a possibility of muscle soreness, particularly 24
to 48 hours after an exercise test. There is also a small chance of musculosketetal injury
associated with vigorous exercise.
Subject's Initials
Appendix B (Con't.)
In addition, you may experience some soreness in your fingertips from where the blood is
drawn. A short-term creatine monohydrate supplementation regimen of 25 grams per day
for 5-6 days has been reported to have no known side effects, providing creatine is
dissolved prior to ingestion. Undissolved creatine may cause slight gastrointestinal
discomfort. Further, the maintenance dose of creatine currently advocated (5 g per day)
to maintain muscle creatine concentration is no greater than that found in some meat-
eaters' diets. There has been anecdotal evidence that creatine consumption causes
muscle cftlmps or strains, but there is no scientific evidence to support these claims.
5. If you would like more information about this study at any time prior to, during, or
following the data collection, you may contact Brian Kelly, at (315) 252-7770 or Betsy
Keller at (607) 274-1683.
6. Withdrawal from the studY:
You are free to withdraw from this study at anytime without penalty. I would
appreciate it if you would inform me of your decision should you decide to do so.
7. Confidentiality:
All data collected in this study will be coded to insure your confidentiality. Your
name will not appear in any reports from this study.
I have read and understand the above document. I agree to participate in this study and
realize that I can withdraw at any time. I also understand that I can and should address
questions related to this study at any time to the researchers involved. I also veriff that I
am at least 18 years ofage.
Name of Subject (please Print)
Signature of Subject Date
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Appendix C
MEDICAL HISTORY/HEALTH HABIT QUESTIONNAIRE
Nalne               Age       Date ofBirth
Home Address
Work Address
Phone#
Phone#
Physician
Familv Historv: Have any blood relatives had? (sister, brother, etc.)
HeartDisease( ) Stroke( ) Diabetes ( ) Highbloodpressure( )
High Cholesterol ( )
Other Conditions/Comments :
Medical/Ilealth Historv: Check if you have ever had:
Hear Disease/Stroke ------ Lung Cancer ------
High Blood Pressure ------ Diabetes -----
Heart Murmur EpilePsY ------
Rheumatic Fever Back injury ------
Skipped, rapid beats, or Arthritis or
irregular rhythm joint problems --------
Cancer ------
Other Conditions/Comments:
Present Heallh: Have you recently experienced:
Chest Pain Surgery/Flo spitalization
Shortness of Breath Ankle/Leg Swelling
Dizziness Joint/Muscle Pain
Fainting____              1lergles_____
Illncss
Appendix C (Con't.)
List all current medications:
Do you currently smoke? Yes
How long have you been smoking?
How many do you smoke a day?
Have you lost or gained more than l0 pounds in the last 30 days? Yes
How much?
Do you currently engage in regular physical activity?
What kind?
Yes No
How Often
Do you experience pain, discomfort or shortness ofbreath during physical activity?
If yes, explain.
When was your last physical?
Have you even been advised by a medical professional not to exercise? Yes
If yes, explain.
No
No
54
Appendix D
ANOVA TABLES
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Table D-3
Sumrnary of the 2x3x4 repeated meazures ANOVA Group x test x bout) for percent
Sollrce                          SS     df    MS
Group
Error 1
Recovery Trial
Group by Recovery Trial
E;rr.or 2
Cycling Bout
Group by Exercise Bout
Error 3
Bout by Recovery Trial
Cycling Bout by Recovery Trial by Group 39.67 4
Residual                                1210.03   48     25.21
Note. One creatine subject did not complete bout four of the 45 second recovery test.
Percent fatigue for each bout was calculated as (highest - lowest power output) / highest
power output) X 100.
*p<0.05
1076.55    1   1076.55  1.29  0.278
10001.72   12    833.48
7238    2
53.46    2
1644.31   24
57.66    2
69.64    2
958.27   24
79.30    4
36.19  0.53  0.596
26.73  0.39  0.496
68.51
28.83  0.72
34.82  0.87  0.431
39.93
19.83  0.79  0.540
9.92  0.39  0.812
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Table D-4
Summary of the 2x3 repeated measures ANOVA (group x test) for percent fatigue across
all four cycling bouts for the creatine (.n=7) and placebo (n:7) Croups.
Source SS df MS F p
Group 21.37 1 21.37 0.27 0.615
Error l, 959.30 12 79.94
Recovery Trial 152.27 2 76.28 5.50 0.011'
Group by Recovery Trial 8.21 2 4.ll 0.30 0.746
Residual 332,.57 24 13.86
Note. One creatine zubject did not complete bout four of the 45 second re@very test.
Percent fatigue for each bout was calculated as ((highest - lowest power output)/ highest
power output) X 100.
*p<0.05
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Table D-5
Summary of the 2x3x4 repeated measures ANOVA (group x test x bout) for blood lactate
during repeated cycling bouts for the creatine (n:7) and placebo (n:7) groups.
Source SS df MS
Group
Error I
Recovery Trial
Group by Recovery Trial
Enor 2
Cycling Bout
Group by Cycling Bout
Error 3
Bout by Recovery Trial
Cycling Bout by Recovery Trial by Group
Residual
0.12
153.75
2.92
7.18
25.06
1409.50
8.11
109.98
21.20
12.40
42.01   44
0.12. 0.01 0.93
12.81
1.46 1.40 0.27
3.59 3.44 0.05*
1.04
704.75 140.98 0.00**
4.05 0.81 0.46
5.00
5.30 5.55 0.00*'
3.10 3.25 0.02
0.95
1
12
2
2
24
2
2
22
4
4
Note.For one creatine subiect,b100d lacttte was not measured pre―exercis ,and p ■‐
exercise bout two.
ホ p<0.05
ホ*p<0.01
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Table D-6
0ne―wav analvsis ofvanance beh″een ttsups for Oost‐supplementation bodv weight.
Sotrce                          SS     df    MS     F    p
Group                                   195.00    1    195.00  0.509 0.489
Residua1                               4594.52   12    382.76
Tota1                                 4789.52   13    368.43
*p<0.05
Table D-7
One-way analysis of variance between groups for post-supplementation creatinine
excretion.
Group
Residual
Total
6.32 I 6.32 60.85 0.000*.
t.25 t2 0.10
7.56   13      0.58
* p<0.05
**p<0.01
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Appendix E
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